Literature DB >> 20818304

Gastrointestinal stromal tumors and extra-gastrointestinal tract neoplasms.

Badr AbdullGaffar1.   

Abstract

OBJECTIVES: Gastrointestinal stromal tumor (GIST) is a relatively uncommon and predominantly sporadic tumor of the gastrointestinal tract (GIT). Infrequently, it can be associated with other neoplasms, notably GIT carcinomas and, rarely, extra-gastrointestinal tumors. Whether this concomitant occurrence is a causal association or a coincidence is not yet resolved, nor is its clinical importance determined. We attempted to investigate the frequency and spectrum of associations between non-incidental GISTs and extra-GIT tumors.
METHODS: A retrospective review study was carried out over 18 years of records. All confirmed cases of GISTs were retrieved from the pathology files of our institution. Each case was investigated for any synchronous or metachronous association with GIT or extra-GIT tumors.
RESULTS: Five (24%) out of 21 cases of GISTs were found to be either synchronously or metachronously associated with extra-gastrointestinal neoplasms in 55% of the women with GISTs. Males had no such association.
CONCLUSION: The cause of the association between non-incidental GISTs and extra-GIT tumors is difficult to determine. In the majority of cases, this association is most likely a coincidental finding. Synchronous occurrence with certain tumors, however, may suggest a nonrandom causal association. We report a case series study of the possible association of GISTs with extra-GIT tumors in female patients. Like other studies, we suggest that patients--especially women--with GISTs should be clinically investigated and followed up for the possibility of coexisting GIT and extra-GIT neoplasms.

Entities:  

Mesh:

Year:  2010        PMID: 20818304     DOI: 10.1097/SMJ.0b013e3181ef2f41

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  8 in total

1.  Synchronous occurrence of gastrointestinal stromal tumour and ovarian neoplasm in a patient presenting with acute cholecystitis.

Authors:  Omair Shariq; Aaron Odedra; Anastasia-Stefania Alexopoulos; Stuart Gould; Ramawad Soobrah
Journal:  J Gastrointest Cancer       Date:  2012-03

2.  BRCA 1/2 gene mutation and gastrointestinal stromal tumours: a potential association.

Authors:  Julie Waisbren; Regina Uthe; Kalliopi Siziopikou; Virginia Kaklamani
Journal:  BMJ Case Rep       Date:  2015-07-06

Review 3.  The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  J Gastrointest Cancer       Date:  2015-12

4.  Primary malignant mesenchymoma of bladder: Case report and review of the literature.

Authors:  Zecheng Yang; Xiaodong Yang; Xianqi Lu; Lijian Gao; Gang Li; Xuefeng Zhang
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

Review 5.  Gastrointestinal Stromal Tumor (GIST) and Synchronous Intra-Abdominal Liposarcoma: A Report of Two Rare Cases and Literature Review.

Authors:  Alexandros Diamantis; Athina A Samara; Ioannis Baloyiannis; Dimitrios Symeonidis; Andreas-Marios Diamantis; Maria Tolia; Konstantinos Bouliaris; Georgios Koukoulis; Konstantinos Tepetes
Journal:  Int J Surg Oncol       Date:  2021-09-01

Review 6.  Primary extragastrointestinal stromal tumour of the whole abdominal cavity, omentum, peritoneum and mesentery: a case report and review of the literature.

Authors:  Nassir Alhaboob Arabi; Abdulmagid M Musaad; Elsaggad Eltayeb Ahmed; Abdulmunem A Abdo; Ahmed M Elhassan; Hiba Hassan; Nasreeldeen Adam; Mohamed Abdelazeem; Mohamed A Ibnouf
Journal:  J Med Case Rep       Date:  2014-10-10

7.  Extragastrointestinal Stromal Tumor (EGIST): A 16-Year Experience of 13 Cases Diagnosed at a Single Center.

Authors:  Engin Hatipoğlu
Journal:  Med Sci Monit       Date:  2018-05-19

8.  Diffuse primary extra-gastrointestinal stromal tumor of the peritoneum: A rare case report.

Authors:  Liang-Ji Lu; Xiao-Pei Xu; Fei Dong; Jie Min
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.